Literature DB >> 9694544

Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance.

M Laakso1, S Lehto.   

Abstract

Diabetes mellitus is a strong risk factor for all manifestations of atherosclerotic vascular disease, coronary heart disease (CHD), cerebrovascular disease and peripheral vascular disease. Diabetes can be classified into two main subtypes, insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus (NIDDM). This review focuses only on NIDDM. Also, in impaired glucose tolerance (IGT), a precursor stage of diabetes, the risk of macrovascular disease is substantially increased. NIDDM and IGT are known to be associated with several adverse cardiovascular risk factors, including hypertension, obesity, central obesity, hyperinsulinemia and serum lipid and lipoprotein abnormalities, characterized mainly by elevated serum total triglycerides and low high-density lipoprotein cholesterol. Practically no information is available on the role of different cardiovascular risk factors to predict macrovascular complications in subjects with IGT. The role of different cardiovascular risk factors with respect to the risk of CHD, stroke and peripheral vascular disease will be discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9694544     DOI: 10.1016/s0021-9150(97)00314-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  20 in total

1.  Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience.

Authors:  Rajendra Pradeepa; Adamsha Nazir; Viswanathan Mohan
Journal:  Heart Asia       Date:  2012-01-01

2.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

3.  Increased risk for cardiovascular outcomes and effect of cholesterol-lowering pravastatin therapy in patients with diabetes mellitus in the pravastatin anti-atherosclerosis trial in the elderly (PATE).

Authors:  Toshitsugu Ishikawa; Hideki Ito; Yasuyoshi Ouchi; Yasuo Ohashi; Yasushi Saito; Haruo Nakamura; Hajime Orimo
Journal:  Curr Ther Res Clin Exp       Date:  2005-01

4.  Tissue Factor, Tissue Factor Pathway Inhibitor and Factor VII Activity in Cardiovascular Complicated Type 2 Diabetes Mellitus.

Authors:  Rehab S El-Hagracy; Gihan M Kamal; Inas M Sabry; Abeer A Saad; Nahla F Abou El Ezz; Hesham A R Nasr
Journal:  Oman Med J       Date:  2010-07

Review 5.  Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease.

Authors:  P Palatini
Journal:  Curr Hypertens Rep       Date:  2001-09       Impact factor: 5.369

6.  Clinical significance of plasma mannose concentrations in healthy and diabetic dogs.

Authors:  A Mori; T Sato; P Lee; M Furuuchi; H Tazaki; K Katayama; H Mizutani; T Sako; T Arai
Journal:  Vet Res Commun       Date:  2008-12-13       Impact factor: 2.459

7.  Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S).

Authors:  S Savastano; R Valentino; A Belfiore; N De Luca; A de Alteriis; F Orio; S Palomba; A M Villani; C Falconi; G Lupoli; G Lombardi; C Falcone
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

8.  STREPTOZOTOCIN-INDUCED DIABETES MELLITUS - A PARADOX OF HIGH INTRINSIC PLATELET REACTIVITY AND LOW IN VITRO PLATELET AGGREGATION.

Authors:  A Scridon; M Perian; A Mărginean; A Vântu; D Gherţescu; C Fişcă; V Halatiu; T Grigoras; R C Şerban
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

9.  Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition.

Authors:  Maria Rosaria Rizzo; Michelangela Barbieri; Raffaele Marfella; Giuseppe Paolisso
Journal:  Diabetes Care       Date:  2012-06-11       Impact factor: 19.112

10.  Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes--a prospective observational cohort study.

Authors:  Elsa M Dahlén; Niclas Bjarnegård; Toste Länne; Fredrik H Nystrom; Carl J Ostgren
Journal:  Cardiovasc Diabetol       Date:  2013-03-28       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.